Luprolide acetate gel depot clinical trials
A product of Leuprolide; its studies count on that page too.
How each study uses luprolide acetate gel depot is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the luprolide acetate gel depot studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 9 Apr 1985 · LUPRON · NDA 019010 (FDA, Drugs@FDA; as Leuprolide)
- European Union
- 24 May 2022 · Camcevi · EMEA/H/C/005034 (EMA; as Leuprolide)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
9 studies that test it; most in 2014 (3)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2011 | 1 |
| 2014 | 3 |
| 2019 | 1 |
| 2020 | 1 |
| 2024 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 5
HanAll BioPharma Co., Ltd. (2) · Pfizer (1) · Weill Medical College of Cornell University (1) · Institut Cancerologie de l'Ouest (1) · Chesapeake Urology Research Associates (1) · Ontario Clinical Oncology Group (OCOG) (1) · McGill University Health Centre/Research Institute of the McGill University Health Centre (1) · Astellas Pharma Europe Ltd. (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- A dosage form of Leuprolide source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test luprolide acetate gel depot.
- Dec 2026Postop Hypofractionated Radiation Therapy and LHRH in Patients With Prostate CancerPhase 2 · McGill University Health Centre/Research Institute of the McGill University Health Centre
Studies
Open first, then newest update. How each study uses luprolide acetate gel depot is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 9
- Study of Recurrence-directed Therapy (RDT) With or Without Androgen-Deprivation Therapy (ADT) In Patients With Radio-recurrent Oligo-metastatic Hormone/Castrate Sensitive Prostate Cancer (romCSPC)RecruitingPhase 2Ontario Clinical Oncology Group (OCOG)NCT06654336Written as ELIGARD 22.5mg
- Postop Hypofractionated Radiation Therapy and LHRH in Patients With Prostate CancerRecruitingPhase 2McGill University Health Centre/Research Institute of the McGill University Health CentreNCT04249154Written as Eligard
- Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)Active, not recruitingPhase 3PfizerNCT02319837Written as Leuprolide Open Label
- The LUCINDA Trial: LeUprolide Plus Cholinesterase Inhibition to Reduce Neurological Decline in Alzheimer'sCompletedPhase 2Weill Medical College of Cornell UniversityNCT03649724Written as Eligard 22.5Mg Suspension for Injection
- Efficacy and Safety of Leuprolide Acetate 45 mg in Subjects With Central Precocious PubertyActive, not recruitingPhase 4HanAll BioPharma Co., Ltd.NCT06926933Written as Eligard® 45 mg
- Salvage Radiotherapy Combined With Hormonotherapy in Oligometastatic Pelvic Node Relapses of Prostate CancerCompletedPhase 2Institut Cancerologie de l'OuestNCT02274779Written as ELIGARD
- Evaluate Recovery of Testosterone for Patients Using EligardCompletedPhase 4Chesapeake Urology Research AssociatesNCT01136226Written as Eligard (TM)
- A Study in Patients With Metastatic Prostate Cancer to Assess How the Drug Eligard®, Affects Certain Markers in Blood and Urine, Which Are Indicators for the DiseaseTerminatedPhase 4Astellas Pharma Europe Ltd.NCT01933022Written as Eligard
- Efficacy and Safety Study of ELIGARD 22.5mg With Prostate CancerCompletedPhase 4HanAll BioPharma Co., Ltd.NCT01511874Written as ELIGARD 22.5mg
Given beside what is tested · 2 — luprolide acetate gel depot is usual care or a partner of the new treatment
- Neo-DAB: Darolutamide and Abemaciclib in Prostate CancerTerminatedPhase 1Praful Ravi, MB BCHir, MRCPNCT05617885Written as GNRH-A Leuprolide Acetate
- Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical ProstatectomyCompletedPhase 3SanofiNCT00283062Written as Leuprolide acetate ( ELIGARD®) Hormonal Therapy
Codes
What other systems call luprolide acetate gel depot · ClinicalTrials.gg INT004714
- MeSH (NLM) C493311luprolide acetate gel depotOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C493311 | luprolide acetate gel depot | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.